News & Events
Join us at the the Neuro4D conference in Mainz, Germany. Our CEO, Hannes Hahne, will present work we have done together with our partner, Rodin Therapeutics, on complex-selective HDAC inhibitors for the treatment of synaptopathies. If you are interested in meeting us to learn more about our chemical proteomics technology platform, feel free to drop us an e-mail at info(at)omicscouts.com. Find out more.